New Formulations

• Apply typical BE criteria

• In many cases, we do not expect the formulations to be bioequivalent.

• Examples:

  • Modified release formulations and prodrugs
  • Formulations with increased bioavailability

Previous slide

Next slide

Back to first slide

View graphic version